Trials / Completed
CompletedNCT01062165
Effect of Weight and/or Obesity on Caspofungin Drug Concentrations
Population Pharmacokinetic Analysis of Caspofungin in Overweight and Obese Volunteers
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Texas Tech University Health Sciences Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will find how weight affects the dosing of a drug called caspofungin. Currently, the amount of caspofungin a patient receives is the same regardless of the patient's weight.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Caspofungin | Caspofungin 70mg IV (each volunteer will only receive one dose of the study drug) |
Timeline
- Start date
- 2010-02-01
- Primary completion
- 2010-12-01
- Completion
- 2010-12-01
- First posted
- 2010-02-04
- Last updated
- 2017-02-10
- Results posted
- 2013-01-21
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01062165. Inclusion in this directory is not an endorsement.